Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 18:12:1624844.
doi: 10.3389/fnut.2025.1624844. eCollection 2025.

The dietary inflammation index and body mass index mediate the association between the dietary index for gut microbiota and sarcopenia in older women: evidence from NHANES 2011-2018

Affiliations

The dietary inflammation index and body mass index mediate the association between the dietary index for gut microbiota and sarcopenia in older women: evidence from NHANES 2011-2018

Xiaoyan Zhang et al. Front Nutr. .

Abstract

Background: The dietary index of gut microbiota (DI-GM) was developed to assess dietary quality by reflecting the diversity of the gut microbiota composition. This study examined the relationship between DI-GM and sarcopenia risk and evaluated the potential moderating effects of diet-related factors on sarcopenia risk in adult individuals.

Methods: This cross-sectional study included 8,872 adults from the National Health and Nutrition Examination Survey (NHANES) database between 2011 and 2018. Weighted multivariable logistic regression, restricted cubic splines (RCS), and subgroup analyses were used to investigate the association between DI-GM and sarcopenia. Mediation analysis was employed to examine the impact of the dietary inflammatory index (DII), systemic immune-inflammatory index (SII), and body mass index (BMI) on the relationship between DI-GM and sarcopenia.

Results: Among the eligible participants, 773 (8.71%) had sarcopenia. The mean DI-GM value was significantly lower in the sarcopenia group than in the non-sarcopenia group (4.76 vs. 4.99, p < 0.001). Multivariable logistic regression analysis revealed a negative association between DI-GM and the risk of sarcopenia, irrespective of whether the independent variable was analyzed as a continuous variable or in quartiles in the fully adjusted model (Model 3, continuous variable: OR = 0.91, 95% confidence interval (CI): 0.88-0.95, p < 0.001; Q4 vs. Q1: OR = 0.67, 95% CI = 0.56-0.80, p < 0.001, p for trend<0.001). The RCS curves illustrated a non-linear relationship between DI-GM and sarcopenia risk. Subgroup analyses indicated an inverse relationship between DI-GM and sarcopenia risk across various covariates in the study. Mediation analysis demonstrated that 46.32, 2.29, and 29.63% of the association between DI-GM and sarcopenia was mediated by the DII, SII, and BMI, respectively.

Conclusion: A lower DI-GM score was strongly associated with an increased risk of sarcopenia, particularly among older adults, women, individuals with hypertension, and individuals with reduced physical activity. The DII and BMI may mediate the relationship between DI-GM and sarcopenia risk, suggesting that a diet promoting gut health could be an effective strategy for preventing sarcopenia. Additional longitudinal or interventional studies are required to substantiate the findings of this study.

Keywords: DI-GM; NHANES; dysbiosis; gut microbiota; sarcopenia.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Flow chart for the inclusion and exclusion of study participants.
Figure 2
Figure 2
Restricted cubic spline plots for the association between DI-GM and sarcopenia. Adjusted for sex, age, ethnicity, education level, PIR, marital status, smoking, drinking, CVD, diabetes, hypertension, and physical activity.
Figure 3
Figure 3
Forest plot of stratified analysis and interaction effects on the association between DI-GM and sarcopenia. The model was adjusted for sex, age, ethnicity, education level, PIR, marital status, smoking, alcohol consumption, CVD, diabetes, hypertension, and physical activity.
Figure 4
Figure 4
Estimated proportion of the association between DI-GM and sarcopenia mediated by DII, SII, and BMI.

References

    1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. (2019) 393:2636–46. doi: 10.1016/S0140-6736(19)31138-9, PMID: - DOI - PubMed
    1. Sayer AA, Cooper R, Arai H, Cawthon PM, Ntsama Essomba MJ, Fielding RA, et al. Sarcopenia. Nat Rev Dis Primers. (2024) 10:68. doi: 10.1038/s41572-024-00550-w - DOI - PubMed
    1. Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. (2023) 144:155533. doi: 10.1016/j.metabol.2023.155533, PMID: - DOI - PubMed
    1. Guralnik JM, Cawthon PM, Bhasin S, Fielding R, Magaziner J, Cruz-Jentoft AJ, et al. Limited physician knowledge of sarcopenia: a survey. J Am Geriatr Soc. (2023) 71:1595–602. doi: 10.1111/jgs.18227, PMID: - DOI - PubMed
    1. Murphy CH, McCarthy SN, Roche HM. Nutrition strategies to counteract sarcopenia: a focus on protein, LC n-3 PUFA and precision nutrition. Proc Nutr Soc. (2023) 82:419–31. doi: 10.1017/S0029665123003555, PMID: - DOI - PubMed

LinkOut - more resources